Nutex Health Inc./$NUTX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Ticker
$NUTX
Sector
Primary listing
Employees
830
Headquarters
Website
NUTX Metrics
BasicAdvanced
$637M
9.55
$12.01
1.98
-
Price and volume
Market cap
$637M
Beta
1.98
52-week high
$184.28
52-week low
$40.67
Average daily volume
110K
Financial strength
Current ratio
2.274
Quick ratio
2.175
Long term debt to equity
112.947
Total debt to equity
124.185
Dividend payout ratio (TTM)
10.25%
Interest coverage (TTM)
9.65%
Profitability
EBITDA (TTM)
227.275
Gross margin (TTM)
51.95%
Net profit margin (TTM)
10.76%
Operating margin (TTM)
33.39%
Effective tax rate (TTM)
18.90%
Revenue per employee (TTM)
$750,000
Management effectiveness
Return on assets (TTM)
22.34%
Return on equity (TTM)
78.92%
Valuation
Price to earnings (TTM)
9.549
Price to revenue (TTM)
0.966
Price to book
3.22
Price to tangible book (TTM)
3.77
Price to free cash flow (TTM)
8.682
Free cash flow yield (TTM)
11.52%
Free cash flow per share (TTM)
13.206
Growth
Revenue change (TTM)
141.25%
Earnings per share change (TTM)
-232.81%
3-year revenue growth (CAGR)
22.99%
3-year earnings per share growth (CAGR)
-26.91%
Bulls say / Bears say
Nutex Health’s total revenue for Q2 2025 jumped 220.7% year-over-year to $244.0 million, reflecting accelerated growth across its hospital network and population health segments. (Investing.com)
The company’s gross profit margin improved to 51.2% in Q2 2025 from 29.7% in the prior-year quarter, underscoring enhanced operational efficiency and higher reimbursement rates. (Investing.com)
Nutex Health announced a $25 million stock repurchase program in August 2025, signaling management’s confidence in the company’s intrinsic value and commitment to offset dilution. (Investing.com)
The company delayed filing its Q2 2025 10-Q due to non-cash accounting adjustments related to stock-based compensation, raising concerns about financial reporting controls and audit readiness. (Investing.com)
A class-action lawsuit filed in September 2025 alleges Nutex Health engaged in deceptive billing practices with third-party vendor HaloMD, accusing the company of inflating revenues and misleading shareholders. (PRNewswire)
Short-seller Blue Orca Capital’s July 22, 2025 report accused Nutex and HaloMD of a scheme to defraud insurers via inflated arbitration claims, casting doubt on the sustainability of reported revenue. (Access Newswire)
Data summarised monthly by Lightyear AI. Last updated on 3 Nov 2025.
NUTX News
AllArticlesVideos
Deadline Soon: Nutex Health Inc. (NUTX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Business Wire3 weeks ago
NUTX Deadline: Rosen Law Firm Urges Nutex Health Inc. (NASDAQ: NUTX) Stockholders to Contact the Firm for Information About Their Rights
Business Wire3 weeks ago
Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman
Business Wire4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nutex Health Inc. stock?
Nutex Health Inc. (NUTX) has a market cap of $637M as of November 10, 2025.
What is the P/E ratio for Nutex Health Inc. stock?
The price to earnings (P/E) ratio for Nutex Health Inc. (NUTX) stock is 9.55 as of November 10, 2025.
Does Nutex Health Inc. stock pay dividends?
No, Nutex Health Inc. (NUTX) stock does not pay dividends to its shareholders as of November 10, 2025.
When is the next Nutex Health Inc. dividend payment date?
Nutex Health Inc. (NUTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Nutex Health Inc.?
Nutex Health Inc. (NUTX) has a beta rating of 1.98. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.